HALO logo
halo search icon
4015
Jamjoom Pharmaceuticals Factory Co.

4015 · Jamjoom Pharmaceuticals Factory Co.

161.20

SAR
0.00 (0.00%)
22/06/2026 12:00:00 AM
Price change (7D)

Unlock stock Insights

Create a free account to unlock price targets, recommendations, and commentary.

Overview

Market Cap

SAT11.33B

PE

21.50

EV/EBITDA

19.1

DIV Yield

2.8%

Payout Ratio

60%

MQV Rating

5Very Weak

As at 22/06/2026 12:00:00 AM

Price Chart

Description

Jamjoom Pharmaceuticals Factory Co. engages in the development, manufacturing, and marketing of generic pharmaceutical products. It operates through Pharmaceutical Products and Consumer Health Products segments. The Pharmaceutical Products segment represents medicines or drugs that are essential for the prevention and treatment of diseases, and protection of public health. The Consumer Health Products segment covers products that does not require the oversight of a health care practitioner. The firm's products are primarily sold in Saudi Arabia, Egypt, Iraq, Gulf countries, and North Africa countries. The company was founded by Yousuf Mohammed Salah Abdulaziz Jamjoom on September 22, 1994 and is headquartered in Jeddah, Saudi Arabia.

  • All-Companies
  • All-Consensus
  • HALO All
  • HALO Price Momentum
  • HALO Small
  • Near Resistance

Key Fundamentals

EPS 3 yr Growth

170.70%

EBITDA Margin

33.60%

Operating Cashflow

ر.س412m

Free Cash Flow Return

25.60%

ROIC

28.80%

Interest Coverage

504.80

Quick Ratio

4.40

Performance

52 weeks range

Low 125 - 181.3

Trade Value (12mth)

US$602,200.00

1 week

2.09%

1 month

4%

YTD

11.94%

1 year

1.38%

All time high

202.40

Additional Data

Shares Outstanding (Fully Diluted)

70m

HALO Sector

Healthcare

Next Company Report Date

02-Mar-27

Next Ex Dividend Date

02-Mar-26

Next Dividend Pay Date

15-Mar-26

Reporting Currency

SAR

Short Sell (% of issue)

0.00

Consensus score

Lock Icon/10

Recommendation

Buy

Target price

Lock Icon

Deviation

Lock Icon

Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Very Strong

Halo Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Very Weak

Momentum

Price

Very Strong

Earnings

Neutral

Growth

Earnings

Neutral

Dividends

Strong

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

Value

Lock Icon

Consensus

Lock Icon

Yield

Lock Icon

News & Announcements

No announcements available.

See beyond the curve.

One solution for research, investing and portfolio management.
Want to learn more?Frequently asked questions.
1
What is the current share price of Jamjoom Pharmaceuticals Factory Co. (4015:SAU)?
Halo FAQ
The current share price of Jamjoom Pharmaceuticals Factory Co. (4015:SAU) is SAR﷼161.20.
2
What is the 52-week high share price for Jamjoom Pharmaceuticals Factory Co. (4015:SAU)?
Halo FAQ
The 52-week high share price for Jamjoom Pharmaceuticals Factory Co. (4015:SAU) is SAR﷼181.30.
3
What is the 52-week low share price for Jamjoom Pharmaceuticals Factory Co. (4015:SAU)?
Halo FAQ
The 52-week low share price for Jamjoom Pharmaceuticals Factory Co. (4015:SAU) is SAR﷼125.00.
4
What is the dividend yield for Jamjoom Pharmaceuticals Factory Co. (4015:SAU)?
Halo FAQ
The current TTM dividend payout for Jamjoom Pharmaceuticals Factory Co. (4015:SAU) is 2.80.
5
What was Jamjoom Pharmaceuticals Factory Co. (4015:SAU) last dividend payment?
Halo FAQ
The last dividend payment of Jamjoom Pharmaceuticals Factory Co. (4015:SAU) is SAR﷼2.00.
6
What is the franking level for Jamjoom Pharmaceuticals Factory Co. (4015:SAU)?
Halo FAQ
Jamjoom Pharmaceuticals Factory Co. (4015:SAU) has a franking level of 0.00%.
7
In which sector is Jamjoom Pharmaceuticals Factory Co. (4015:SAU) classified?
Halo FAQ
Jamjoom Pharmaceuticals Factory Co. (4015:SAU) is classified in the Healthcare.
8
What is the price-to-earnings (P/E) ratio for Jamjoom Pharmaceuticals Factory Co. (4015:SAU)?
Halo FAQ
The current P/E ratio for Jamjoom Pharmaceuticals Factory Co. (4015:SAU) is 21.50.